You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

MACRODANTIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Macrodantin patents expire, and when can generic versions of Macrodantin launch?

Macrodantin is a drug marketed by Almatica and is included in one NDA.

The generic ingredient in MACRODANTIN is nitrofurantoin, macrocrystalline. Twenty-eight suppliers are listed for this compound. Additional details are available on the nitrofurantoin, macrocrystalline profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MACRODANTIN?
  • What are the global sales for MACRODANTIN?
  • What is Average Wholesale Price for MACRODANTIN?
Summary for MACRODANTIN
Drug patent expirations by year for MACRODANTIN
Drug Prices for MACRODANTIN

See drug prices for MACRODANTIN

Drug Sales Revenue Trends for MACRODANTIN

See drug sales revenues for MACRODANTIN

Recent Clinical Trials for MACRODANTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Roswell Park Cancer InstitutePhase 4
National Cancer Institute (NCI)Phase 4
University Hospital, GenevaPhase 4

See all MACRODANTIN clinical trials

Pharmacology for MACRODANTIN

US Patents and Regulatory Information for MACRODANTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Almatica MACRODANTIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 016620-003 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Almatica MACRODANTIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 016620-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Almatica MACRODANTIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 016620-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.